RhumbLine Advisers
STTK icon

RhumbLine Advisers’s Shattuck Labs STTK Stock Holding History

RhumbLine Advisers’s Portfolio STTK Stock Details STTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-51,053
Closed -$48.5K – 4257
2025
Q1 		$48.5K Buy
51,053
+1,808
+4% +$2.23K ﹤0.01% 3585
2024
Q4 		$59.6K Sell
49,245
-767
-2% -$950 ﹤0.01% 3613
2024
Q3 		$175K Buy
50,012
+2,767
+6% +$10.3K ﹤0.01% 3302
2024
Q2 		$182K Buy
+47,245
New +$384K ﹤0.01% 3275
2022
Q2 		– Sell
-26,270
Closed -$112K – 3229
2022
Q1 		$112K Buy
26,270
+2,310
+10% +$13.1K ﹤0.01% 2871
2021
Q4 		$204K Sell
23,960
-473
-2% -$6.51K ﹤0.01% 2828
2021
Q3 		$498K Buy
24,433
+1,221
+5% +$26.1K ﹤0.01% 2543
2021
Q2 		$673K Buy
23,212
+9,967
+75% +$291K ﹤0.01% 2426
2021
Q1 		$387K Buy
13,245
+857
+7% +$36K ﹤0.01% 2603
2020
Q4 		$649K Buy
+12,388
New +$398K ﹤0.01% 2329

Other funds holding STTK

PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CEI
Clark Estates Inc New York $416M AUM 6.04% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return

RhumbLine Advisers's STTK Position: Q2 2025 in Review

RhumbLine Advisers sold out of Shattuck Labs (STTK) in Q2 2025, closing a stake of 51,053 shares — an estimated $48.5K sold.

RhumbLine Advisers first reported a position in STTK in Q4 2020 and held it in 10 quarters. The position peaked at $673K in Q2 2021. 61 funds tracked by Wall St. Rank hold STTK as of Q2 2025.

  • RhumbLine Advisers reported no remaining Shattuck Labs position as of Q2 2025 after selling out during the quarter.
  • RhumbLine Advisers sold 51,053 Shattuck Labs shares in Q2 2025, an estimated $48.5K.
  • RhumbLine Advisers first reported a position in Shattuck Labs in Q4 2020 and held it in 10 quarters.
  • RhumbLine Advisers's Shattuck Labs position peaked at $673K in Q2 2021.
  • 61 funds tracked by Wall St. Rank held Shattuck Labs as of Q2 2025.

Based on RhumbLine Advisers's 13F filing for Q2 2025, filed 12 Aug 2025.